What is Anticimex?
Founded in 1934, Anticimex has evolved into a cornerstone of the international facility management and hygiene industry. The company provides comprehensive pest control and building environment services, catering to a diverse portfolio of commercial and residential clients. By integrating advanced monitoring technologies with traditional sanitation expertise, Anticimex maintains a competitive edge in ensuring health and safety standards across multiple continents. Its long-standing history, combined with a modern, data-driven approach to pest management, positions the firm as a critical partner for enterprises seeking to mitigate biological risks and maintain regulatory compliance in complex environments.
How much funding has Anticimex raised?
Anticimex has raised a total of $200M across 1 funding round:
Debt
$200M
Debt (2022): $200M with participation from Morgan Stanley
Key Investors in Anticimex
Morgan Stanley
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management, and investment management services to corporations and institutions worldwide.
What's next for Anticimex?
The recent influx of capital is expected to accelerate the company's strategic expansion and technological integration. As Anticimex navigates the current economic landscape, the focus will likely shift toward enhancing its digital service platforms and expanding its reach in emerging markets. By utilizing this debt-based financing, the firm is well-positioned to pursue inorganic growth opportunities, such as targeted acquisitions of regional service providers, while simultaneously investing in sustainable, eco-friendly pest control innovations. This strategic trajectory ensures that Anticimex remains at the forefront of the hygiene and facility management sector, providing long-term value to its stakeholders and clients alike.
See full Anticimex company page
